"#",Jurisdiction,Kind,Display Key,Lens ID,Publication Date,Publication Year,Application Number,Application Date,Priority Numbers,Earliest Priority Date,Title,Abstract,Applicants,Inventors,Owners,URL,Document Type,Has Full Text,Cites Patent Count,Cited by Patent Count,Simple Family Size,Extended Family Size,Sequence Count,CPC Classifications,IPCR Classifications,US Classifications,NPL Citation Count,NPL Resolved Citation Count,NPL Resolved Lens ID(s),NPL Resolved External ID(s),NPL Citations,Legal Status
1,EP,A4,EP 3206689 A4,054-739-892-225-656,2018-05-09,2018,EP 15851085 A,2015-10-14,US 201462063937 P;;US 2015/0055607 W,2014-10-14,INHIBITORS OF LOW MOLECULAR WEIGHT PROTEIN TYROSINE PHOSPHATASE AND USES THEREOF,,LA JOLLA INST OF ALLERGY & IMMUNOLOGY;;SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST,BOTTINI NUNZIO;;ZOU JIWEN;;GANJI SANTHI R;;STANFORD STEPHANIE;;PINKERTON ANTHONY;;CHUNG THOMAS;;HEDRICK MICHAEL;;ARDECKY ROBERT,SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE (2020-06-24);;LA JOLLA INSTITUTE OF ALLERGY & IMMUNOLOGY (2020-06-24),https://lens.org/054-739-892-225-656,Search Report,no,7,0,12,12,0,C07D215/42;;C07D403/12;;C07D401/04;;C07D401/12;;C07D405/04;;C07D405/12;;C07D409/04;;C07D239/94;;C07D215/46;;A61P29/00;;A61P3/04;;A61P3/06;;A61P43/00;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;A61P3/10;;C07D401/12;;C07D405/12;;C07D401/04;;C07D403/12;;C07D215/42;;C07D405/04;;C07D409/04;;C07D239/94;;C07D215/46,A61K31/4706;;C07D215/02,,18,17,046-003-992-284-125;;032-678-056-901-669;;079-161-783-179-776;;000-926-173-490-933;;048-182-658-495-911;;011-516-603-548-355;;160-336-815-867-379;;127-890-485-604-024;;000-172-492-345-479;;050-744-095-528-487;;041-746-653-812-961;;070-755-130-016-006;;006-664-159-623-585;;091-677-397-907-802;;075-311-399-790-568;;024-382-834-409-310;;050-481-713-876-015,10.1016/j.tet.2004.09.082;;10.1016/j.tet.2011.04.040;;10.1016/j.tetlet.2004.03.139;;10.1021/ja034181r;;12797801;;10.1016/s0960-894x(99)00291-7;;10406648;;10.1016/0040-4020(95)01110-2;;10.1002/jhet.5570430628;;10.1016/0223-5234(96)88249-3;;10.1021/jm00109a031;;2033597;;10.1002/prac.19321330102;;10.1016/j.bmc.2006.09.059;;17049254;;10.1021/jm020374y;;12646034;;10.1021/jm400227z;;23634668;;pmc3714011;;10.1021/ol060815y;;16706542;;10.1055/s-2005-918419;;10.1016/s0223-5234(97)86176-4;;10.1016/s0040-4039(01)00553-6,"ROSSI E ET AL: ""Divergent sequential reactions of beta-(2-aminophenyl)-alpha,beta-ynones with nitrogen nucleophiles"", TETRAHE, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 60, no. 50, 6 December 2004 (2004-12-06), pages 11391 - 11398, XP004628598, ISSN: 0040-4020, DOI: 10.1016/J.TET.2004.09.082;;MALOSE J MPHAHLELE ET AL: ""One-pot palladium-catalyzed CI and CH bond activation and subsequent SuzukiMiyaura cross-coupling of 2-aryl-3-iodo-4-(phenylamino)quinolines with arylboronic acids"", TETRAHEDRON, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 67, no. 25, 11 April 2011 (2011-04-11), pages 4689 - 4695, XP028222234, ISSN: 0040-4020, [retrieved on 20110428], DOI: 10.1016/J.TET.2011.04.040;;PALIAKOV EKATERINA ET AL: ""Boron tribromide mediated debenzylation of benzylamino and benzyloxy groups"", TETRAHEDRON LETTERS, vol. 45, no. 21, 24 March 2004 (2004-03-24), pages 4093 - 4095, XP085010780, ISSN: 0040-4039, DOI: 10.1016/J.TETLET.2004.03.139;;CHAIRES JONATHAN B ET AL: ""Triplex selective 2-(2-naphthyl)quinoline compounds: origins of affinity and new design principles"", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, AMERICAN CHEMICAL SOCIETY, US, vol. 125, no. 24, 18 June 2003 (2003-06-18), pages 7272 - 7283, XP002459378, ISSN: 0002-7863, DOI: 10.1021/JA034181R;;STREKOWSKI L ET AL: ""Structure-activity relationship analysis of substituted 4-quinolinamines, antagonists of immunostimulatory CpG-oligodeoxynucleotides"", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, PERGAMON, AMSTERDAM, NL, vol. 9, no. 13, 5 July 1999 (1999-07-05), pages 1819 - 1824, XP004168845, ISSN: 0960-894X, DOI: 10.1016/S0960-894X(99)00291-7;;STREKOWSKI L ET AL: ""Amination by Lithium Alkylamide Reagents of Ketimines Derived from 2-(Trifluoromethyl)anilines and Methyl Halophenyl Ketones and Their Cyclization Products 2-(Halophenyl)quinolin-4-amines"", TETRAHEDRON, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 52, no. 9, 26 February 1996 (1996-02-26), pages 3273 - 3282, XP004104352, ISSN: 0040-4020, DOI: 10.1016/0040-4020(95)01110-2;;MARTIAL SAY ET AL: ""Synthesis of 2-phenylquinolin-4-amines substituted with diverse amino and aminoalkyl groups"", JOURNAL OF HETEROCYCLIC CHEMISTRY, WILEY-BLACKWELL PUBLISHING, INC, US, vol. 43, no. 6, 1 November 2006 (2006-11-01), pages 1613 - 1620, XP002759818, ISSN: 0022-152X, [retrieved on 20090313], DOI: 10.1002/JHET.5570430628;;KIREEV D ET AL: ""Molecular modeling and quantitative structure-activity studies of anti-HIV-1 2-heteroarylquinoline-4-amines"", EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, EDITIONS SCIENTIFIQUE ELSEVIER, PARIS, FR, vol. 30, no. 5, 1 January 1995 (1995-01-01), pages 395 - 402, XP004040159, ISSN: 0223-5234, DOI: 10.1016/0223-5234(96)88249-3;;STREKOWSKI L ET AL: ""SYNTHESIS AND QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP ANALYSISOF 2-(ARYL OR HETEROARYL)QUINOLIN-4-AMINES, A NEW CLASS OF ANTI-HIV-1 AGENTS"", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, vol. 34, no. 5, 1 January 1991 (1991-01-01), pages 1739 - 1746, XP002907102, ISSN: 0022-2623, DOI: 10.1021/JM00109A031;;HANNS JOHN: ""Chinolinderivate, XXXIV. Derivate der 2-Phenyl-chinolin-4'-carbonsäure und 2-Phenyl-4'-amino-chinolin"", JOURNAL FÜR PRAKTISCHE CHEMIE : PRACTICAL APPLICATIONS AND APPLIED CHEMISTRY : COVERING ALL ASPECTS OF APPLIED CHEMISTRY, vol. 133, no. 1-2, 1 January 1932 (1932-01-01), DE, pages 13 - 18, XP055457515, ISSN: 0021-8383, DOI: 10.1002/prac.19321330102;;PALIAKOV ET AL: ""Fujita-Ban QSAR analysis and CoMFA study of quinoline antagonists of immunostimulatory CpG-oligodeoxynucleotides"", BIOORGANIC & MEDICINAL CHEMI, PERGAMON, GB, vol. 15, no. 1, 15 November 2006 (2006-11-15), pages 324 - 332, XP005764614, ISSN: 0968-0896, DOI: 10.1016/J.BMC.2006.09.059;;STREKOWSKI L ET AL: ""Synthesis and activity of substituted 2-phenylquinolin-4-amines, antagonists of immunostimulatory CpG-oligodeoxynucleotides"", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, vol. 46, no. 7, 27 March 2003 (2003-03-27), pages 1242 - 1249, XP002759814, ISSN: 0022-2623, [retrieved on 20030220], DOI: 10.1021/JM020374Y;;FEIRAN ZHANG ET AL: ""Pyridinylquinazolines Selectively Inhibit Human Methionine Aminopeptidase-1 in Cells"", JOURNAL OF MEDICINAL CHEMISTRY, vol. 56, no. 10, 23 May 2013 (2013-05-23), pages 3996 - 4016, XP055192537, ISSN: 0022-2623, DOI: 10.1021/jm400227z;;ZHAO-KUI WAN ET AL: ""An efficient direct amination of cyclic amides and cyclic ureas"", ORGANIC LETTERS , 14(23), 6012-6015 CODEN: ORLEF7; ISSN: 1523-7052,, vol. 8, no. 11, 5 June 2006 (2006-06-05), pages 2425 - 2428, XP002492817, ISSN: 1523-7060, DOI: 10.1021/OL060815Y;;VIPAN KUMAR ET AL: ""A Convenient Route to Biologically Important Quinazolines Using N -Arylamino-1,3-diazabuta-1,3-dienes"", SYNTHESIS, vol. 2005, no. 18, 1 January 2005 (2005-01-01), STUTTGART, DE., pages 3059 - 3062, XP055457657, ISSN: 0039-7881, DOI: 10.1055/s-2005-918419;;MOKROSZ J ET AL: ""Structure-activity relationship studies of CNS agents. Part 29. N-Methylpiperazino-substituted derivatives of quinazoline, phthalazine and quinoline as novel @a""1, 5-HT""1""A and 5-HT""2""A receptor ligands"", EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, EDITIONS SCIENTIFIQUE ELSEVIER, PARIS, FR, vol. 31, no. 12, 1 January 1996 (1996-01-01), pages 973 - 980, XP004071792, ISSN: 0223-5234, DOI: 10.1016/S0223-5234(97)86176-4;;ROSSI E ET AL: ""Concise synthesis of fused polycyclic quinolines"", TETRAHEDRON LET, ELSEVIER, AMSTERDAM, NL, vol. 42, no. 22, 28 May 2001 (2001-05-28), pages 3705 - 3708, XP004249064, ISSN: 0040-4039, DOI: 10.1016/S0040-4039(01)00553-6;;See also references of WO 2016061280A1",ACTIVE
2,EP,A1,EP 3206689 A1,083-200-320-594-168,2017-08-23,2017,EP 15851085 A,2015-10-14,US 201462063937 P;;US 2015/0055607 W,2014-10-14,INHIBITORS OF LOW MOLECULAR WEIGHT PROTEIN TYROSINE PHOSPHATASE AND USES THEREOF,,LA JOLLA INST OF ALLERGY & IMMUNOLOGY;;SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST,BOTTINI NUNZIO;;ZOU JIWEN;;GANJI SANTHI R;;STANFORD STEPHANIE;;PINKERTON ANTHONY;;CHUNG THOMAS;;HEDRICK MICHAEL;;ARDECKY ROBERT,SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE (2020-06-24);;LA JOLLA INSTITUTE OF ALLERGY & IMMUNOLOGY (2020-06-24),https://lens.org/083-200-320-594-168,Patent Application,yes,0,0,12,12,0,C07D215/42;;C07D403/12;;C07D401/04;;C07D401/12;;C07D405/04;;C07D405/12;;C07D409/04;;C07D239/94;;C07D215/46;;A61P29/00;;A61P3/04;;A61P3/06;;A61P43/00;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;A61P3/10;;C07D401/12;;C07D405/12;;C07D401/04;;C07D403/12;;C07D215/42;;C07D405/04;;C07D409/04;;C07D239/94;;C07D215/46,A61K31/4706;;C07D215/02,,0,0,,,,ACTIVE
3,EP,B1,EP 3206689 B1,127-812-589-250-191,2021-12-08,2021,EP 15851085 A,2015-10-14,US 201462063937 P;;US 2015/0055607 W,2014-10-14,INHIBITORS OF LOW MOLECULAR WEIGHT PROTEIN TYROSINE PHOSPHATASE AND USES THEREOF,,LA JOLLA INST OF ALLERGY & IMMUNOLOGY;;SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST,BOTTINI NUNZIO;;ZOU JIWEN;;GANJI SANTHI R;;STANFORD STEPHANIE;;PINKERTON ANTHONY;;CHUNG THOMAS;;HEDRICK MICHAEL;;ARDECKY ROBERT,SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE (2020-06-24);;LA JOLLA INSTITUTE OF ALLERGY & IMMUNOLOGY (2020-06-24),https://lens.org/127-812-589-250-191,Granted Patent,yes,9,0,12,12,0,C07D215/42;;C07D403/12;;C07D401/04;;C07D401/12;;C07D405/04;;C07D405/12;;C07D409/04;;C07D239/94;;C07D215/46;;A61P29/00;;A61P3/04;;A61P3/06;;A61P43/00;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;A61P3/10;;C07D401/12;;C07D405/12;;C07D401/04;;C07D403/12;;C07D215/42;;C07D405/04;;C07D409/04;;C07D239/94;;C07D215/46,A61K31/4706;;A61P3/04;;A61P3/06;;A61P29/00;;A61P43/00;;C07D215/02;;C07D215/42;;C07D215/46;;C07D239/94;;C07D401/04;;C07D401/12;;C07D403/12;;C07D405/04;;C07D405/12;;C07D409/04,,20,0,,,"ROSSI E ET AL: ""Divergent sequential reactions of beta-(2-aminophenyl)-alpha,beta-ynones with nitrogen nucleophiles"", TETRAHE, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 60, no. 50, 6 December 2004 (2004-12-06), pages 11391-11398, XP004628598, ISSN: 0040-4020, DOI: 10.1016/J.TET.2004.09.082;;MALOSE J MPHAHLELE ET AL: ""One-pot palladium-catalyzed CI and CH bond activation and subsequent SuzukiMiyaura cross-coupling of 2-aryl-3-iodo-4-(phenylamino)quinolines with arylboronic acids"", TETRAHEDRON, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 67, no. 25, 11 April 2011 (2011-04-11), pages 4689-4695, XP028222234, ISSN: 0040-4020, DOI: 10.1016/J.TET.2011.04.040 [retrieved on 2011-04-28];;PALIAKOV EKATERINA ET AL: ""Boron tribromide mediated debenzylation of benzylamino and benzyloxy groups"", TETRAHEDRON LETTERS, vol. 45, no. 21, 24 March 2004 (2004-03-24), pages 4093-4095, XP085010780, ISSN: 0040-4039, DOI: 10.1016/J.TETLET.2004.03.139;;CHAIRES JONATHAN B ET AL: ""Triplex selective 2-(2-naphthyl)quinoline compounds: origins of affinity and new design principles"", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, AMERICAN CHEMICAL SOCIETY, US, vol. 125, no. 24, 18 June 2003 (2003-06-18), pages 7272-7283, XP002459378, ISSN: 0002-7863, DOI: 10.1021/JA034181R;;STREKOWSKI L ET AL: ""Structure-activity relationship analysis of substituted 4-quinolinamines, antagonists of immunostimulatory CpG-oligodeoxynucleotides"", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, PERGAMON, AMSTERDAM, NL, vol. 9, no. 13, 5 July 1999 (1999-07-05), pages 1819-1824, XP004168845, ISSN: 0960-894X, DOI: 10.1016/S0960-894X(99)00291-7;;STREKOWSKI L ET AL: ""Amination by Lithium Alkylamide Reagents of Ketimines Derived from 2-(Trifluoromethyl)anilines and Methyl Halophenyl Ketones and Their Cyclization Products 2-(Halophenyl)quinolin-4-amines"", TETRAHEDRON, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 52, no. 9, 26 February 1996 (1996-02-26), pages 3273-3282, XP004104352, ISSN: 0040-4020, DOI: 10.1016/0040-4020(95)01110-2;;MARTIAL SAY ET AL: ""Synthesis of 2-phenylquinolin-4-amines substituted with diverse amino and aminoalkyl groups"", JOURNAL OF HETEROCYCLIC CHEMISTRY, WILEY-BLACKWELL PUBLISHING, INC, US, vol. 43, no. 6, 1 November 2006 (2006-11-01), pages 1613-1620, XP002759818, ISSN: 0022-152X, DOI: 10.1002/JHET.5570430628 [retrieved on 2009-03-13];;KIREEV D ET AL: ""Molecular modeling and quantitative structure-activity studies of anti-HIV-1 2-heteroarylquinoline-4-amines"", EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, EDITIONS SCIENTIFIQUE ELSEVIER, PARIS, FR, vol. 30, no. 5, 1 January 1995 (1995-01-01), pages 395-402, XP004040159, ISSN: 0223-5234, DOI: 10.1016/0223-5234(96)88249-3;;STREKOWSKI L ET AL: ""SYNTHESIS AND QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP ANALYSISOF 2-(ARYL OR HETEROARYL)QUINOLIN-4-AMINES, A NEW CLASS OF ANTI-HIV-1 AGENTS"", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, vol. 34, no. 5, 1 January 1991 (1991-01-01), pages 1739-1746, XP002907102, ISSN: 0022-2623, DOI: 10.1021/JM00109A031;;HANNS JOHN: ""Chinolinderivate, XXXIV. Derivate der 2-Phenyl-chinolin-4'-carbonsäure und 2-Phenyl-4'-amino-chinolin"", JOURNAL FÜR PRAKTISCHE CHEMIE : PRACTICAL APPLICATIONS AND APPLIED CHEMISTRY : COVERING ALL ASPECTS OF APPLIED CHEMISTRY, vol. 133, no. 1-2, 1 January 1932 (1932-01-01), pages 13-18, XP55457515, DE ISSN: 0021-8383, DOI: 10.1002/prac.19321330102;;PALIAKOV ET AL: ""Fujita-Ban QSAR analysis and CoMFA study of quinoline antagonists of immunostimulatory CpG-oligodeoxynucleotides"", BIOORGANIC & MEDICINAL CHEMI, PERGAMON, GB, vol. 15, no. 1, 15 November 2006 (2006-11-15), pages 324-332, XP005764614, ISSN: 0968-0896, DOI: 10.1016/J.BMC.2006.09.059;;STREKOWSKI L ET AL: ""Synthesis and activity of substituted 2-phenylquinolin-4-amines, antagonists of immunostimulatory CpG-oligodeoxynucleotides"", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, vol. 46, no. 7, 27 March 2003 (2003-03-27) , pages 1242-1249, XP002759814, ISSN: 0022-2623, DOI: 10.1021/JM020374Y [retrieved on 2003-02-20];;FEIRAN ZHANG ET AL: ""Pyridinylquinazolines Selectively Inhibit Human Methionine Aminopeptidase-1 in Cells"", JOURNAL OF MEDICINAL CHEMISTRY, vol. 56, no. 10, 23 May 2013 (2013-05-23), pages 3996-4016, XP55192537, ISSN: 0022-2623, DOI: 10.1021/jm400227z;;ZHAO-KUI WAN ET AL: ""An efficient direct amination of cyclic amides and cyclic ureas"", ORGANIC LETTERS , 14(23), 6012-6015 CODEN: ORLEF7; ISSN: 1523-7052,, vol. 8, no. 11, 5 June 2006 (2006-06-05), pages 2425-2428, XP002492817, ISSN: 1523-7060, DOI: 10.1021/OL060815Y;;VIPAN KUMAR ET AL: ""A Convenient Route to Biologically Important Quinazolines Using N -Arylamino-1,3-diazabuta-1,3-dienes"", SYNTHESIS, vol. 2005, no. 18, 1 January 2005 (2005-01-01), pages 3059-3062, XP55457657, STUTTGART, DE. ISSN: 0039-7881, DOI: 10.1055/s-2005-918419;;MOKROSZ J ET AL: ""Structure-activity relationship studies of CNS agents. Part 29. N-Methylpiperazino-substituted derivatives of quinazoline, phthalazine and quinoline as novel @a""1, 5-HT""1""A and 5-HT""2""A receptor ligands"", EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, EDITIONS SCIENTIFIQUE ELSEVIER, PARIS, FR, vol. 31, no. 12, 1 January 1996 (1996-01-01), pages 973-980, XP004071792, ISSN: 0223-5234, DOI: 10.1016/S0223-5234(97)86176-4;;ROSSI E ET AL: ""Concise synthesis of fused polycyclic quinolines"", TETRAHEDRON LET, ELSEVIER, AMSTERDAM, NL, vol. 42, no. 22, 28 May 2001 (2001-05-28), pages 3705-3708, XP004249064, ISSN: 0040-4039, DOI: 10.1016/S0040-4039(01)00553-6;;DATABASE PUBCHEM [Online] 16 September 2004 XP055432030 Retrieved from NCBI NCBI Database accession no. 7047;;DATABASE PUBCHEM [Online] 10 March 2014 XP055432031 Retrieved from NCBI NCBI Database accession no. CID 73050850;;None",ACTIVE
4,US,A1,US 2017/0247340 A1,008-334-551-140-335,2017-08-31,2017,US 201515518331 A,2015-10-14,US 201515518331 A;;US 201462063937 P;;US 2015/0055607 W,2014-10-14,Inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase and Uses Thereof,"Herein are provided, inter alia, compounds capable of modulating the level of activity of low molecular weight protein tyrosine phosphatase (LMPTP) and methods of using the same. In embodiments, the compound has a structure according to Formula (I-A).",LA JOLLA INST OF ALLERGY & IMMUNOLOGY;;SANFORD BURNHAM MED RES INST,BOTTINI NUNZIO;;ZOU JIWEN;;GANJI SANTHI R;;STANFORD STEPHANIE;;PINKERTON ANTHONY;;CHUNG THOMAS;;HEDRICK MICHAEL;;ARDECKY ROBERT,SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE (2015-06-24);;SANFORD BURNHAM MEDICAL RESEARCH INSTITUTE (2017-04-20);;LA JOLLA INSTITUTE OF ALLERGY & IMMUNOLOGY (2017-04-28),https://lens.org/008-334-551-140-335,Patent Application,yes,13,2,12,12,0,C07D215/42;;C07D403/12;;C07D401/04;;C07D401/12;;C07D405/04;;C07D405/12;;C07D409/04;;C07D239/94;;C07D215/46;;A61P29/00;;A61P3/04;;A61P3/06;;A61P43/00;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;A61P3/10;;C07D401/12;;C07D405/12;;C07D401/04;;C07D403/12;;C07D215/42;;C07D405/04;;C07D409/04;;C07D239/94;;C07D215/46,C07D239/94;;C07D215/46;;C07D401/12;;C07D405/12,,5,3,107-934-340-215-139;;032-246-906-350-930;;059-295-214-740-525,25383516;;pmc4248606;;10.1038/nature13885;;2085882;;10.1248/cpb.38.3024;;10.1055/s-2002-34835,"Liu et al., Overcoming the Limitations of Directed C-H Functionalizations of Heterocycles, Nature, Vol. 515, No. 7527, pages 389-393. (Year: 2014);;STN printout of Registry No. 345341-94-8 (2001); 1789298-88-9 (2015); 1787785-59-4 (2015); 1787609-44-2 (2015); 1125451-90-2 (2009); 1125438-39-2 (2009); 1125418-33-8 (2009); 860724-06-7 (2005); 856096-27-0 (2005); and 753417-30-0 (2004).;;Ishihara et al., Synthesis of Isoindolo[2,1-a]quinoline Derivatives and Their Effects on N.sub.2-Induced Hypoxia, Chemical Pharmaceutical Bulletin, Vol. 38, No. 11, pages 3024-3030. (Year: 1990);;Hanns et al., Quinoline Derivatives, XXXIV Derivatives of 2-Phenylquinoline-4-carboxylic acid and 2-Phenyl-4'-aminoquinoline, Journal fuer Praktische Chemie, Vol. 133, pages 13-18. (Year: 1932);;Hamersak et al., Efficient Synthesis of Chiral Amides of 2-(2'-Carboxyphenyl)-4-Hydroxy-Quinoline, Synthesis, Vol. 15, pages 2174-2176. (Year: 2002)",ACTIVE
5,WO,A1,WO 2016/061280 A1,033-257-653-333-760,2016-04-21,2016,US 2015/0055607 W,2015-10-14,US 201462063937 P,2014-10-14,INHIBITORS OF LOW MOLECULAR WEIGHT PROTEIN TYROSINE PHOSPHATASE AND USES THEREOF,"Herein are provided, inter alia , compounds capable of modulating the level of activity of low molecular weight protein tyrosine phosphatase (LMPTP) and methods of using the same. In embodiments, the compound has a structure according to Formula (I-A).",JOLLA INST OF ALLERGY & IMMUNOLOGY;;SANFORD BURNHAM MED RES INST;;BOTTINI NUNZIO;;ZOU JIWEN;;GANJI SANTHI R;;STANFORD STEPHANIE,BOTTINI NUNZIO;;ZOU JIWEN;;GANJI SANTHI R;;STANFORD STEPHANIE;;PINKERTON ANTHONY;;CHUNG THOMAS;;HEDRICK MICHAEL;;ARDECKY ROBERT,,https://lens.org/033-257-653-333-760,Patent Application,yes,2,13,12,12,0,C07D215/42;;C07D403/12;;C07D401/04;;C07D401/12;;C07D405/04;;C07D405/12;;C07D409/04;;C07D239/94;;C07D215/46;;A61P29/00;;A61P3/04;;A61P3/06;;A61P43/00;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;A61P3/10;;C07D401/12;;C07D405/12;;C07D401/04;;C07D403/12;;C07D215/42;;C07D405/04;;C07D409/04;;C07D239/94;;C07D215/46,C07D215/02;;A61K31/4706,,13,3,007-364-858-655-289;;118-248-556-697-527;;077-295-491-167-117,10.1002/jps.2600660104;;833720;;10.1201/9781420000955;;10.1002/0471220574,"DATABASE PUBCHEM [O] 16 September 2004 (2004-09-16), XP055432030, retrieved from NCBI Database accession no. 7047;;DATABASE PUBCHEM [O] 10 March 2014 (2014-03-10), retrieved from NCBI Database accession no. 73050850;;BERGE ET AL.: ""Pharmaceutical Salts"", JOURNAL OF PHARMACEUTICAL SCIENCE, vol. 66, 1977, pages 1 - 19, XP002675560, DOI: 10.1002/jps.2600660104;;LIEBERMAN, PHARMACEUTICAL DOSAGE FORMS, vol. 1-3, 1992;;LLOYD, THE ART, SCIENCE AND TECHNOLOGY OF PHARMACEUTICAL COMPOUNDING, 1999;;PICKAR, DOSAGE CALCULATIONS, 1999;;""Remington: The Science and Practice of Pharmacy"", 2003, LIPPINCOTT, WILLIAMS & WILKINS;;""Fieser and Fieser's Reagents for Organic Synthesis"", vol. 1-40, 1991, JOHN WILEY AND SONS;;""Larock's Comprehensive Organic Transformations"", vol. 1-5, 1989, ELSEVIER SCIENCE PUBLISHERS;;CAREYSUNDBERG: ""Advanced Organic Chemistry"", vol. A and B, 2000, PLENUM;;GREENEWUTS: ""Protective Groups in Organic Synthesis"", 1999, JOHN WILEY & SONS;;KOCIENSKI: ""Protective Groups"", 1994, THIEME VERLAG;;WADE ET AL., J. PATHOL., 2015, pages 1 - 13",PENDING
6,CA,A1,CA 2964113 A1,057-330-377-616-156,2016-04-21,2016,CA 2964113 A,2015-10-14,US 201462063937 P;;US 2015/0055607 W,2014-10-14,INHIBITORS OF LOW MOLECULAR WEIGHT PROTEIN TYROSINE PHOSPHATASE AND USES THEREOF,"Herein are provided, inter alia, compounds capable of modulating the level of activity of low molecular weight protein tyrosine phosphatase (LMPTP) and methods of using the same. In embodiments, the compound has a structure according to Formula (I-A).",LA JOLLA INST OF ALLERGY & IMMUNOLOGY;;SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST,BOTTINI NUNZIO;;ZOU JIWEN;;GANJI SANTHI R;;STANFORD STEPHANIE;;PINKERTON ANTHONY;;CHUNG THOMAS;;HEDRICK MICHAEL;;ARDECKY ROBERT,,https://lens.org/057-330-377-616-156,Patent Application,no,0,0,12,12,0,C07D215/42;;C07D403/12;;C07D401/04;;C07D401/12;;C07D405/04;;C07D405/12;;C07D409/04;;C07D239/94;;C07D215/46;;A61P29/00;;A61P3/04;;A61P3/06;;A61P43/00;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;A61P3/10;;C07D401/12;;C07D405/12;;C07D401/04;;C07D403/12;;C07D215/42;;C07D405/04;;C07D409/04;;C07D239/94;;C07D215/46,A61K31/4706;;C07D215/02,,0,0,,,,DISCONTINUED
7,CN,A,CN 107427506 A,148-565-499-380-132,2017-12-01,2017,CN 201580067939 A,2015-10-14,US 201462063937 P;;US 2015/0055607 W,2014-10-14,INHIBITORS OF LOW MOLECULAR WEIGHT PROTEIN TYROSINE PHOSPHATASE AND USES THEREOF,"The invention discloses inhibitors of low molecular weight protein tyrosine phosphatase and uses thereof. Herein are provided, inter alia, compounds capable of modulating the level of activity of low molecular weight protein tyrosine phosphatase (LMPTP) and methods of using the same. In embodiments, the compound has a structure according to Formula (I-A) (as shown in the description).",JOLLA INST OF ALLERGY & IMMUNOLOGY;;SANFORD BURNHAM MED RES INST,PINKERTON ANTHONY;;CHUNG THOMAS;;HEDRICK MICHAEL;;ARDECKY ROBERT;;BOTTINI NUNZIO;;ZOU JIWEN;;GANJI SANTHI R;;STANFORD STEPHANIE,,https://lens.org/148-565-499-380-132,Patent Application,no,7,1,12,12,0,C07D215/42;;C07D403/12;;C07D401/04;;C07D401/12;;C07D405/04;;C07D405/12;;C07D409/04;;C07D239/94;;C07D215/46;;A61P29/00;;A61P3/04;;A61P3/06;;A61P43/00;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;A61P3/10;;C07D401/12;;C07D405/12;;C07D401/04;;C07D403/12;;C07D215/42;;C07D405/04;;C07D409/04;;C07D239/94;;C07D215/46,A61K31/4706;;C07D215/02,,18,13,000-172-492-345-479;;048-182-658-495-911;;041-746-653-812-961;;000-926-173-490-933;;160-336-815-867-379;;006-664-159-623-585;;070-755-130-016-006;;002-881-165-517-725;;091-677-397-907-802;;075-311-399-790-568;;079-161-783-179-776;;032-678-056-901-669;;011-516-603-548-355,10.1021/jm00109a031;;2033597;;10.1016/s0960-894x(99)00291-7;;10406648;;10.1016/j.bmc.2006.09.059;;17049254;;10.1021/ja034181r;;12797801;;10.1002/jhet.5570430628;;10.1021/jm400227z;;23634668;;pmc3714011;;10.1021/jm020374y;;12646034;;10.1002/prac.19311300121;;10.1021/ol060815y;;16706542;;10.1055/s-2005-918419;;10.1016/j.tetlet.2004.03.139;;10.1016/j.tet.2011.04.040;;10.1016/0040-4020(95)01110-2,"STREKOWSKI L ET AL: ""Synthesis and quantitative structure-activity relationship analysis of 2-(aryl or heteroaryl)quinolin-4-amines, a new class of anti-HIV-1 agents"", 《J. MED. CHEM.》;;STREKOWSKI L ET AL: ""Structure-Activity Relationship analysis of substituted 4-quinolinamines, antagonists of immunostimulatory CPG-oligodeoxynucleotides"", 《BIOORGANIC & MEDICINAL CHEMISTRY LETTERS》;;PALIAKOV ET AL,: ""Fujita-Ban QSAR analysis and CoMFA study of quinoline antagonists of immunostimulatory CpG-oligodeoxynucleotides"", 《BIOORGANIC & MEDICINAL CHEMISTRY》;;KIREEV D ET AL: ""molecular modeling and quantitative structure-activity studies of anti-HIV-1 2-heteroarylquinoline-4-amines"", 《EUR. J. MED. CHEM.》;;FEIRAN ZHANG ET AL: ""Structure-activity relationship studies of CNS agents. Part 29. N-methyipiperazino-substituted derivatives of quinazoline,phthalazine and quinoline as novel α1, 5-HT1A and 5-HT2A receptor ligands"", 《EUR. J. MED. CHEM》;;CHAIRES JONATHAN B ET AL: ""Triplex Selective 2-(2-naphthyl)quinoline compounds: Origins of Affinity and New Design Principles"", 《J. AM. CHEM. SOC》;;MARTIAL SAY ET AL: ""Synthesis of 2-phenylquinolin-4-amines substituted with diverse amino and aminoalkyl groups"", 《J. HETEROCYCLIC CHEM.》;;FEIRAN ZHANG ET AL: ""Pyridinylquinazolines selectively inhibit human methionine aminopeptidase-1 in cells"", 《J. MED. CHEM》;;STREKOWSKI L ET AL: ""Synthesis and activity of substituted 2-phenylquinolin-4-amines, antagonists of immunostimulatory CpG-oligodeoxynucleotides"", 《J. MED. CHEM》;;HANNS JOHN ET AL: ""Chinolinderivate, XXXIV derivate der 2-phenyl-chinolin 4’-carbonsaure und 2-phenyl-4’-amino-chinolin"", 《JOURNAL FUR PRAKTISCHE CHEMIE N. F. BAND》;;ZHAO-KUI WAN ET AL: ""An efficient direct amination of cyclic amides and cyclic ureas"", 《ORGANIC LETTERS》;;VIPAN KUMAR ET AL: ""A convenient route of biologically important quinazolines using N-arylamino-1,3-diazabuta-1,3-dienes"", 《SYNTHESIS》;;PALIAKOV EKATERINA ET AL: ""Boron tribromide mediated debenzylation of benzylamino and benzylatioxy groups"", 《TETRAHEDRON》;;MALOSE J. MPHAHLELE ET AL: ""One-pot palladium-catalyzed C-I and C-H bond activation and subsequent Suzuki-Miyanura cross-coupling of 2- aryl -3-iodo -4-(phenylamino)quinolines with arylboronic acids"", 《TETRAHEDRON》;;ROSSI E ET AL: ""Divergent sequential reaction of β-(2-aminophenyl)-α, β-ynones with nitrogen nucleophiles"", 《TETRAHEDRON》;;STREKOWSKI L ET AL: ""Amination by lithium alkylamide reagents of ketimines derived from 2-(trifluoromethyl)anilines and methyl halophenyl ketones and their cyclization products 2-(halophenyl)quinolin-4-amines"", 《TETRAHEDRON》;;CAS登记号：91-22-5等: ""“STN检索报告”"", 《数据库REGISTRY（在线）》;;尤启东主编: ""《药物化学》"", 31 August 2011, 北京：人民卫生出版社",DISCONTINUED
8,US,B2,US 10626094 B2,021-425-877-081-333,2020-04-21,2020,US 201515518331 A,2015-10-14,US 201515518331 A;;US 201462063937 P;;US 2015/0055607 W,2014-10-14,Inhibitors of low molecular weight protein tyrosine phosphatase and uses thereof,"Herein are provided, inter alia, compounds capable of modulating the level of activity of low molecular weight protein tyrosine phosphatase (LMPTP) and methods of using the same. In embodiments, the compound has a structure according to Formula (I-A).",LA JOLLA INST OF ALLERGY & IMMUNOLOGY;;SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST,BOTTINI NUNZIO;;ZOU JIWEN;;GANJI SANTHI R;;STANFORD STEPHANIE;;PINKERTON ANTHONY;;CHUNG THOMAS D Y;;HEDRICK MICHAEL;;ARDECKY ROBERT,SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE (2015-06-24);;SANFORD BURNHAM MEDICAL RESEARCH INSTITUTE (2017-04-20);;LA JOLLA INSTITUTE OF ALLERGY & IMMUNOLOGY (2017-04-28),https://lens.org/021-425-877-081-333,Granted Patent,yes,30,4,12,12,0,C07D215/42;;C07D403/12;;C07D401/04;;C07D401/12;;C07D405/04;;C07D405/12;;C07D409/04;;C07D239/94;;C07D215/46;;A61P29/00;;A61P3/04;;A61P3/06;;A61P43/00;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;A61P3/10;;C07D401/12;;C07D405/12;;C07D401/04;;C07D403/12;;C07D215/42;;C07D405/04;;C07D409/04;;C07D239/94;;C07D215/46,A61K31/4709;;A61P9/00;;C07D215/42;;C07D215/46;;C07D239/94;;C07D401/04;;C07D401/12;;C07D403/12;;C07D405/04;;C07D405/12;;C07D409/04,,33,22,107-934-340-215-139;;059-295-214-740-525;;032-246-906-350-930;;059-025-232-135-492;;000-926-173-490-933;;127-890-485-604-024;;075-311-399-790-568;;032-678-056-901-669;;079-161-783-179-776;;041-746-653-812-961;;050-481-713-876-015;;160-336-815-867-379;;048-182-658-495-911;;070-755-130-016-006;;000-172-492-345-479;;011-516-603-548-355;;091-677-397-907-802;;006-664-159-623-585;;050-744-095-528-487;;007-364-858-655-289;;034-020-263-250-274;;073-986-846-231-841,25383516;;pmc4248606;;10.1038/nature13885;;10.1055/s-2002-34835;;2085882;;10.1248/cpb.38.3024;;28346406;;10.1038/nchembio.2344;;pmc5435566;;10.1021/ja034181r;;12797801;;10.1016/0223-5234(96)88249-3;;10.1055/s-2005-918419;;10.1016/j.tet.2011.04.040;;10.1016/j.tetlet.2004.03.139;;10.1016/j.bmc.2006.09.059;;17049254;;10.1016/s0040-4039(01)00553-6;;10.1002/jhet.5570430628;;10.1016/s0960-894x(99)00291-7;;10406648;;10.1021/jm020374y;;12646034;;10.1021/jm00109a031;;2033597;;10.1016/0040-4020(95)01110-2;;10.1021/ol060815y;;16706542;;10.1021/jm400227z;;23634668;;pmc3714011;;10.1002/prac.19321330102;;10.1002/jps.2600660104;;833720;;10.1021/jm200607g;;21988196;;26213100;;pmc5049627;;10.1002/path.4594,"Liu et al., Overcoming the Limitations of Directed C—H Functionalizations of Heterocycles, Nature, vol. 515, No. 7527, pp. 389-393. (Year: 2014).;;CAS printout of WO 2003/059886. (Year: 2003).;;Hamersak et al., Efficient Synthesis of Chiral Amides of 2-(2′-Carboxyphenyl)-4-Hydroxy-Quinoline, Synthesis, vol. 15, pp. 2174-2176. (Year: 2002).;;Ishihara et al., Synthesis of Isoindolo[2,1-a]quinoline Derivatives and Their Effects on N.sub.2-Induced Hypoxia, Chemical Pharmaceutical Bulletin, vol. 38, No. 11, pp. 3024-3030. (Year: 1990).;;Hanns et al., Quinoline Derivatives, XXXIV Derivatives of 2-Phenylquinoline-4-carboxylic acid and 2-Phenyl-4′-aminoquinoline, Journal fuer Praktische Chemie, vol. 133, pp. 13-18. (Year: 1932).;;STN printout of Registry No. 345341-94-8 (2001); 1789298-88-9 (2015); 1787785-59-4 (2015); 1787609-44-2 (2015); 1125451-90-2 (2009); 1125438-39-2 (2009); 1125418-33-8 (2009); 860724-06-7 (2005); 856096-27-0 (2005); and 753417-30-0 (2004).;;PCT/US2018/029749 International Search Report and Written Opinion dated Aug. 14, 2018.;;Saeed et al. Synthesis of Benzo-Fused Six-Membered Aromatic Heterocycles . Der Chemica Sinica 2(1):66-69 (2011).;;Stanford et al. Diabetes reversal by inhibition of the low-molecular-weight tyrosine phosphatase. Nat Chem Biol 13(6):624-632 (2017).;;Chaires et al. Triplex Selective 2-(2-Naphthyl)quinoline Compounds: Origins of Affinity and New Design Principles. J Am Chem Soc 125(24):7272-7283 (2003).;;Kireev et al. Molecular Modeling and Quantitative Structure-Activity Studies of Anti-HIV-1 2-Heteroarylquinoline-4-Amines. Eur J Med Chem 30(5):395-402 (1995).;;Kumar et al. A Convenient Route to Biologically Important Quinazolines Using N-Arylamino-1,3-Diazabuta-1,3-Dienes. Synthesis 2005(18):3059-3062 (2005).;;Mokrosz et al. Structure-activity relationship studies of CNS agents. Part 29. N-Methylpiperazino-substituted derivatives of quinazoline, phthalazine and quinoline as novel α1, 5-HT1A and 5-HT2A receptor ligands. Eur J Med Chem 31(12):973-980 (1996).;;Mphahlele et al. One-Pot Palladium-Catalyzed Ci and Ch Bond Activation and Subsequent Suzukimiyaura Cross-Coupling of 2-Aryl-3-Iodo-4-(Phenylamino)Quinolines With Arylboronic Acids. Tetrahedron 67(25):4689-4695 (2011).;;Paliakov et al. Boron Tribromide Mediated Debenzylation of Benzylamino and Benzyloxy Groups. Tetrahedron Letters 45(21):4093-4095 (2004).;;Paliakov et al. Fujita-Ban QSAR Analysis and CoMFA Study of Quinoline Antagonists of Immunostimulatory CpG-Oligodeoxynucleotides. Bioorg Med Chem 15(1):324-332 (2006).;;Rossi et al. Divergent Sequential Reactions of ß-(2-Aminophenyl)-α,ß-Ynones With Nitrogen Nucleophiles. Tetrahedron 60(50):11391-11398 (2004).;;Rossi et al. Concise Synthesis of Fused Polycyclic Quinolines. Tetrahedron Let 42(22):3705-3708 (2001).;;Say et al. Synthesis of 2-Phenylquinolin-4-Amines Substituted With Diverse Amino and Aminoalkyl Groups. Journal Heterocyclic Chemistry 43(6):1613-1620 (2006).;;Strekowski et al. Structure-Activity Relationship Analysis of Substituted 4-Quinolinamines, Antagonists of Immunostimulatory CpG-Oligodeoxynucleotides. Bioorg Med Chem Lett 9(13):1819-1824 (1999).;;Strekowski et al. Synthesis and Activity of Substituted 2-Phenylquinolin-4-Amines, Antagonists of Immunostimulatory Cpg-Oligodeoxynucleotides. J Med Chem 46(7):1242-1249 (2003).;;Strekowski et al. Synthesis and Quantitative Structure-Activity Relationship Analysisof 2-(Aryl Or Heteroaryl)Quinolin-4-Amines, A New Class of Anti-HIV-1 Agents. J Med Chem 34(5):1739-1746 (2003).;;Strekowski et al. Amination by Lithium Alkylamide Reagents of Ketimines Derived From 2-(Trifluoromethyl)Anilines and Methyl Halophenyl Ketones and Their Cyclization Products 2-(Halophenyl)Quinolin-4-Amines. Tetrahedron 52(9):3273-3282 (1996).;;Wan et al. An Efficient Direct Amination of Cyclic Amides and Cyclic Ureas. Organic Letters (8):11:2425-2428 (2006).;;Zhang et al. Pyridinylquinazolines Selectively Inhibit Human Methionine Aminopeptidase-1 in Cells. J Med Chem 56(10):3996-4016 (2013).;;Von Hanns. Chinolinderivate, XXXIV. Derivate der 2-Phenyl-Chinolin-4′-Carbonsäure and 2-Phenyl-4′-Amino-Chinolin. Journal Fur Praktische Chemie : Practical Applications and Applied Chemistry : Covering All Aspects of Applied Chemistry 133(1-2):13-18 (1932) (Structures in English).;;Berge et al. Pharmaceutical Salts. Journal of Pharmaceutical Sciences 66(1):1-19 (Jan. 1977).;;Maccari et al. Low molecular weight phosphotyrosine protein phosphatases as emerging targets for the design of novel therapeutic agents. J Med Chem 55(1):2-22 (2012);;PCT/US2015/055607 International Preliminary Report on Patentability dated Apr. 27, 2017.;;PCT/US2015/055607 International Search Report and Written Opinion dated Feb. 9, 2016.;;PubChem CID 7047. (69 pgs.) (Created Sep. 16, 2004).;;PubChem CID 73050850. (9 pgs.) (Created Mar. 10, 2014).;;Wade et al. Deletion of low molecular weight protein tyrosine phosphatase (Acp1) protects against stress-induced cardiomyopathy. J Pathol 237(4):482-494 (2015).",ACTIVE
9,US,B2,US 11220486 B2,038-177-510-603-403,2022-01-11,2022,US 202016794076 A,2020-02-18,US 202016794076 A;;US 2015/0055607 W;;US 201462063937 P,2014-10-14,Inhibitors of low molecular weight protein tyrosine phosphatase and uses thereof,"Herein are provided, inter alia , compounds capable of modulating the level of activity of low molecular weight protein tyrosine phosphatase (LMPTP) and methods of using the same. In embodiments, the compound has a structure according to Formula (I-A).",LA JOLLA INST OF ALLERGY & IMMUNOLOGY;;SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST,BOTTINI NUNZIO;;ZOU JIWEN;;GANJI SANTHI R;;STANFORD STEPHANIE;;PINKERTON ANTHONY;;CHUNG THOMAS D Y;;HEDRICK MICHAEL;;ARDECKY ROBERT,SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE (2015-06-24);;SANFORD BURNHAM MEDICAL RESEARCH INSTITUTE (2017-04-20);;LA JOLLA INSTITUTE OF ALLERGY & IMMUNOLOGY (2017-04-28),https://lens.org/038-177-510-603-403,Granted Patent,yes,48,0,12,12,0,C07D215/42;;C07D403/12;;C07D401/04;;C07D401/12;;C07D405/04;;C07D405/12;;C07D409/04;;C07D239/94;;C07D215/46;;A61P29/00;;A61P3/04;;A61P3/06;;A61P43/00;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;A61P3/10;;C07D401/12;;C07D405/12;;C07D401/04;;C07D403/12;;C07D215/42;;C07D405/04;;C07D409/04;;C07D239/94;;C07D215/46,A61K31/517;;C07D215/42;;C07D215/46;;C07D239/94;;C07D401/04;;C07D401/12;;C07D403/04;;C07D403/12;;C07D405/04;;C07D405/12;;C07D409/04;;C07D413/04;;C07D417/04,,56,39,012-926-560-652-328;;028-865-954-612-315;;141-051-120-562-095;;095-035-308-071-355;;042-125-587-093-034;;173-350-271-253-856;;007-364-858-655-289;;000-926-173-490-933;;023-839-453-829-62X;;059-295-214-740-525;;032-246-906-350-930;;127-890-485-604-024;;075-311-399-790-568;;107-934-340-215-139;;034-020-263-250-274;;032-678-056-901-669;;079-161-783-179-776;;041-746-653-812-961;;119-885-048-370-550;;050-481-713-876-015;;160-336-815-867-379;;005-625-687-439-249;;059-025-232-135-492;;048-182-658-495-911;;070-755-130-016-006;;000-172-492-345-479;;011-516-603-548-355;;050-744-095-528-487;;073-986-846-231-841;;091-677-397-907-802;;006-664-159-623-585;;121-957-965-862-749;;036-269-981-108-201;;016-727-047-336-774;;061-318-172-528-77X;;019-614-443-149-709;;001-218-874-375-398;;038-380-919-653-143;;021-469-551-984-174,10.1016/j.ejmech.2010.07.067;;20817329;;10.1007/s00044-014-1144-4;;18044930;;10.1021/jo7020373;;22125085;;10.1002/chem.201102468;;7658441;;10.1021/jm00018a014;;10.3891/acta.chem.scand.34b-0637;;10.1002/jps.2600660104;;833720;;10.1021/ja034181r;;12797801;;10.1016/s0065-7743(06)41027-7;;10.1055/s-2002-34835;;2085882;;10.1248/cpb.38.3024;;10.1016/0223-5234(96)88249-3;;10.1055/s-2005-918419;;25383516;;pmc4248606;;10.1038/nature13885;;10.1021/jm200607g;;21988196;;10.1016/j.tet.2011.04.040;;10.1016/j.tetlet.2004.03.139;;10.1016/j.bmc.2006.09.059;;17049254;;10.1124/pr.56.1.3;;15001663;;10.1016/s0040-4039(01)00553-6;;10.1002/jhet.5570430628;;10.1016/b978-0-08-057123-2.50012-0;;28346406;;10.1038/nchembio.2344;;pmc5435566;;10.1016/s0960-894x(99)00291-7;;10406648;;10.1021/jm020374y;;12646034;;10.1021/jm00109a031;;2033597;;10.1016/0040-4020(95)01110-2;;10.1002/prac.19321330102;;26213100;;pmc5049627;;10.1002/path.4594;;10.1021/ol060815y;;16706542;;10.1021/jm400227z;;23634668;;pmc3714011;;10.1055/s-2002-33908;;10.1016/j.bmcl.2012.01.046;;22321214;;24949670;;pmc4216211;;10.1021/jm5007947;;23509991;;10.1021/jm301665y;;10.1002/jhet.5570340213;;10.1002/cjoc.19910090515;;25894085;;pmc4536915;;10.1038/nchembio.1796;;10.1021/jo800456r;;18461999,"Alafeefy et al., Synthesis, Analgesic and Anti-inflammatory Evaluation of Some Novel Quinazoline Derivatives, European Journal of Medicinal Chemistry, vol. 45, No. 11, pp. 4947-4952 (Year: 2010).;;Paliwal et al. Pharmacophore and Molecular Docking Based Identification of Novel Structurally Diverse PDE-5 Inhibitors, Medicinal Chemistry Research, vol. 24, No. 2, pp. 576-587 (Year: 2015).;;Wan et al., The Scope and Mechanism of Phosphonium-Mediated SNAr Reactions in Heterocyclic Amides and Ureas, Journal of Organic Chemistry, vol. 72, No. 26, pp. 10194-10210 (Year: 2007).;;Van Baelan et al., Synthesis of 4-Aminoquinazolines by Palladium-Catalyzed Intramolecular Imidoylation of N-(2-Bromoaryl) amidines, Chemistry—A European Journal, vol. 17, No. 52, pp. 15039-15044 (Year: 2011).;;Lee et al., Discovery of Potent Cyclic GMP Phosphodiesterase Inhibitors. 2-Pyridyl- and 2-Imidazolylquinazolines Possessing Cyclic GMP Phosphodiesterase and Thromboxane Synthesis Inhibitory Activities, Journal of Medicinal Chemistry, vol. 38, No. 18, pp. 3547-3557 (Year: 1995).;;Nielsen et al., Phosphoramides. XIII.* Phosphorus Pentaoxide-Amine Hydrochloride Mixtures as Reagents in the Synthesis of 4(3H)-Quinazolinones and 4-Quinazolinamines, Acta Chemica Scandinavica vol. B34, No. 9, pp. 637-642 (Year: 1980).;;STN printout of RN 959568-30-0 (Year: 2007).;;STN printout of RN 959562-00-6 (Year: 2007).;;Berge et al. Pharmaceutical Salts. Journal of Pharmaceutical Sciences 66(1):1-19 (Jan. 1977).;;Chaires et al. Triplex Selective 2-(2-Naphthyl)quinoline Compounds: Origins of Affinity and New Design Principles. J Am Chem Soc 125(24):7272-7283 (2003).;;Cho. Recent Advances in Oral Prodrug Discovery. Annual Reports in Medicinal Chemistry 41:395-407 (2006).;;Hamersak et al. Efficient Synthesis of Chiral Amides of 2-(2′-Carboxyphenyl)-4-Hydroxy-Quinoline. Synthesis 15:2174-2176 (2002).;;Ishihara et al. Synthesis of Isoindolo[2,1-a]quinoline Derivatives and Their Effects on N.sub.2-Induced Hypoxia. Chemical Pharmaceutical Bulletin 38(11):3024-3030 (1990).;;Kireev et al. Molecular Modeling and Quantitative Structure-Activity Studies of Anti-HIV-1 2-Heteroarylquinoline-4-Amines. Eur J Med Chem 30(5):395-402 (1995).;;Kumar et al. A Convenient Route to Biologically Important Quinazolines Using N-Arylamino-1,3-Diazabuta-1,3-Dienes. Synthesis 2005(18):3059-3062 (2005).;;Liu et al. Overcoming the Limitations of Directed C—H Functionalizations of Heterocycles. Nature 515(7527):389-393 (2014).;;Maccari et al. Low molecular weight phosphotyrosine protein phosphatases as emerging targets for the design of novel therapeutic agents. J Med Chem 55(1):2-22 (2012).;;Mokrosz et al. Structure-activity relationship studies of CNS agents. Part 29. N-Methylpiperazino-substituted derivatives of quinazoline, phthalazine and quinoline as novel α1, 5-HT1A and 5-HT2A receptor ligands. Eur J Med Chem 31(12):973-980 (1996).;;Mphahlele et al. One-Pot Palladium-Catalyzed Ci and Ch Bond Activation and Subsequent Suzukimiyaura Cross-Coupling of 2-Aryl-3-Iodo-4-(Phenylamino)Quinolines With Arylboronic Acids. Tetrahedron 67(25):4689-4695 (2011).;;Nogrady. Medicinal Chemistry a Biochemical Approach, Oxford University Press, New York, pp. 388-392 (1985).;;Paliakov et al. Boron Tribromide Mediated Debenzylation of Benzylamino and Benzyloxy Groups. Tetrahedron Letters 45(21):4093-4095 (2004).;;Paliakov et al. Fujita-Ban QSAR Analysis and CoMFA Study of Quinoline Antagonists of Immunostimulatory CpG-Oligodeoxynucleotides. Bioorg Med Chem 15(1):324-332 (2006).;;PCT/US2015/055607 International Search Report and Written Opinion dated Feb. 9, 2016.;;PCT/US2018/029749 International Search Report and Written Opinion dated Aug. 14, 2018.;;PubChem CID 7047. (69 pgs.) (Created Sep. 16, 2004).;;PubChem CID 73050850. (9 pgs.) (Created Mar. 10, 2014).;;Rooseboom et al. Enzyme-catalyzed activation of anticancer prodrugs. Pharmacological Reviews 56:53-102 (2004).;;Rossi et al. Divergent Sequential Reactions of ß-(2-Aminophenyl)-α,ß-Ynones With Nitrogen Nucleophiles. Tetrahedron 60(50):11391-11398 (2004).;;Rossi et al. Concise Synthesis of Fused Polycyclic Quinolines. Tetrahedron Let 42(22):3705-3708 (2001).;;Saeed et al. Synthesis of Benzo-Fused Six-Membered Aromatic Heterocycles . Der Chemica Sinica 2(1):66-69 (2011).;;Say et al. Synthesis of 2-Phenylquinolin-4-Amines Substituted With Diverse Amino and Aminoalkyl Groups. Journal Heterocyclic Chemistry 43(6):1613-1620 (2006).;;Silverman. Chapter 8: Prodrugs and Drug Delivery Systems. The Organic Chemistry of Drug Design and Drug Action, Academic Press, Inc., San Diego (pp. 352-401) (1992).;;Stanford et al. Diabetes reversal by inhibition of the low-molecular-weight tyrosine phosphatase. Nat Chem Biol 13(6):624-632 (2017).;;STN printout of Registry No. 345341-94-8 (2001); 1789298-88-9 (2015); 1787785-59-4 (2015); 1787609-44-2 (2015); 1125451-90-2 (2009); 1125438-39-2 (2009); 1125418-33-8 (2009); 860724-06-7 (2005); 856096-27-0 (2005); and 753417-30-0 (10 pgs) (2004).;;Strekowski et al. Structure-Activity Relationship Analysis of Substituted 4-Quinolinamines, Antagonists of Immunostimulatory CpG-Oligodeoxynucleotides. Bioorg Med Chem Lett 9(13):1819-1824 (1999).;;Strekowski et al. Synthesis and Activity of Substituted 2-Phenylquinolin-4-Amines, Antagonists of Immunostimulatory Cpg-Oligodeoxynucleotides. J Med Chem 46(7):1242-1249 (2003).;;Strekowski et al. Synthesis and Quantitative Structure-Activity Relationship Analysisof 2-(Aryl or Heteroaryl)Quinolin-4-Amines, A New Class of Anti-Hiv-1 Agents. J Med Chem 34(5):1739-1746 (2003).;;Strekowski et al. Amination by Lithium Alkylamide Reagents of Ketimines Derived From 2-(Trifluoromethyl)Anilines and Methyl Halophenyl Ketones and Their Cyclization Products 2-(Halophenyl)Quinolin-4-Amines. Tetrahedron 52(9):3273-3282 (1996).;;U.S. Appl. No. 15/518,331 Office Action dated Jan. 18, 2019.;;U.S. Appl. No. 15/518,331 Office Action dated May 10, 2019.;;U.S. Appl. No. 15/518,331 Office Action dated Sep. 10, 2019.;;Von Hanns. Chinolinderivate, XXXIV. Derivate der 2-Phenyl-Chinolin-4′-Carbonsäure and 2-Phenyl-4′-Amino-Chinolin. Journal Fur Praktische Chemie : Practical Applications and Applied Chemistry : Covering All Aspects of Applied Chemistry 133(1-2):13-18 (1932).;;Wade et al. Deletion of low molecular weight protein tyrosine phosphatase (Acp1) protects against stress-induced cardiomyopathy. J Pathol 237(4):482-494 (2015).;;Wan et al. An Efficient Direct Amination of Cyclic Amides and Cyclic Ureas. Organic Letters (8):11:2425-2428 (2006).;;Zhang et al. Pyridinylquinazolines Selectively Inhibit Human Methionine Aminopeptidase-1 in Cells. J Med Chem 56(10):3996-4016 (2013).;;Abbiati et al. An Efficient Synthesis of 2,4-Substituted [1,8]Naphthyridines from 3-(2-Amino-5-methylpyridin-3-yl)-1-arylprop-2-yn-1-ones. Synthesis 2002(13):1912-1916 (2002).;;Batt et al. Immunosuppressive structure-activity relationships of Brequinarand related cinchoninic acid derivatives. Bioorg Med Chem Lett 5(14):1549-54 (1995).;;Bauer et al. Discovery of 4-hydroxy-1,6-naphthyridine-3-carbonitrile derivatives as novel PDE10A inhibitors. Bioorg Med Chem Lett 22(5):1944-1948 (2012).;;Brouwer et al. Development of N-methyl-(2-arylquinolin-4-yl)oxypropanamides as leads to PET radioligands for translocator protein (18 kDa). J Med Chem 57(14):6240-6251 (2014).;;Geschwindner et al. Development of a plate-based optical biosensor fragment screening methodology to identify phosphodiesterase 10A inhibitors. J Med Chem 56(8):3228-3234 (2013).;;Rivalle et al. Ethyl (4-N-acylaminopyridin-3-yl)glyoxylate and 5-azaisatin as new synthons for a route to various new polyheterocycles. Journal of Heterocyclic Chemistry 34(2):441-444 (1997).;;Soliman et al. Nitriles in Heterocyclic synthesis: studies on ethyl 3-amino-4,4-dicyano-3-butenoate. Chinese Journal of Chemistry 9(5):461-6 (1991).;;Soliman et al. Nitriles in Heterocyclic Synthesis-Studies on Ethoxycarbonyl-3-Amino-4, 4-Dicyano-Prop-3-Ene. Revue Rounaine de Chimie 38(9):1097-104 (1993).;;Wallkup et al. Translating slow-binding inhibition kinetics into cellular and in vivo effects. Nat Chem Biol 11(6):416-423 (2015).;;Youssef et al. Utility of 3-aroylprop-2-enoic acid in heterocyclic synthesis. Afinidad: Revista de quimica teörica y aplicada 61(512):304-316 (2004).;;Zong et al. Direct access to 4-carboxy-1,8-naphthyridines and related compounds through Pfitzinger-type chemistry. J Org Chern 73(11):4334-7 (2008).",ACTIVE
10,US,A1,US 2020/0290977 A1,103-691-744-992-998,2020-09-17,2020,US 202016794076 A,2020-02-18,US 202016794076 A;;US 2015/0055607 W;;US 201462063937 P,2014-10-14,Inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase and Uses Thereof,"Herein are provided, inter alia, compounds capable of modulating the level of activity of low molecular weight protein tyrosine phosphatase (LMPTP) and methods of using the same. In embodiments, the compound has a structure according to Formula (I-A).",LA JOLLA INST OF ALLERGY & IMMUNOLOGY;;SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST,BOTTINI NUNZIO;;ZOU JIWEN;;GANJI SANTHI R;;STANFORD STEPHANIE;;PINKERTON ANTHONY;;CHUNG THOMAS D Y;;HEDRICK MICHAEL;;ARDECKY ROBERT,SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE (2015-06-24);;SANFORD BURNHAM MEDICAL RESEARCH INSTITUTE (2017-04-20);;LA JOLLA INSTITUTE OF ALLERGY & IMMUNOLOGY (2017-04-28),https://lens.org/103-691-744-992-998,Patent Application,yes,0,2,12,12,0,C07D215/42;;C07D403/12;;C07D401/04;;C07D401/12;;C07D405/04;;C07D405/12;;C07D409/04;;C07D239/94;;C07D215/46;;A61P29/00;;A61P3/04;;A61P3/06;;A61P43/00;;A61P9/00;;A61P9/04;;A61P9/10;;A61P9/12;;A61P3/10;;C07D401/12;;C07D405/12;;C07D401/04;;C07D403/12;;C07D215/42;;C07D405/04;;C07D409/04;;C07D239/94;;C07D215/46,C07D239/94;;C07D215/42;;C07D215/46;;C07D401/04;;C07D401/12;;C07D403/12;;C07D405/04;;C07D405/12;;C07D409/04,,0,0,,,,ACTIVE
